Ovarian cancer vaccine (Antigen Express)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOvarian cancer vaccine (Antigen Express)

Drug Alias NameHer-2/neu combo vaccineAE-O vaccine

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionCD4-positive T-lymphocytes stimulantsCytotoxic T lymphocytes stimulants

TargetsNot applicable

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAntigen Express Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsOvarian Neoplasms

ATC CodeN/A